We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTW:NASDAQWillis Towers Watson Public Limited Company Analysis

Data as of 2026-05-11 - not real-time

$256.36

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Willis Towers Watson (WTW) is trading at $256.36, well under its 20‑day (≈$279.8), 50‑day (≈$287.0) and 200‑day (≈$315.4) moving averages, signaling a bearish technical backdrop. The 14‑day RSI sits at 31.7, placing the stock in oversold territory, while the MACD remains in a bearish configuration with a negative histogram. Volume has been increasing, providing some support for a potential short‑term bounce toward the identified support level around $246.6. However, the 30‑day realized volatility exceeds 42%, indicating that price swings may be wide and erratic.
Fundamentally, WTW delivers solid earnings with an 8.5% revenue growth year‑over‑year, healthy margins (gross 42%, operating 20%) and a 20.6% ROE, while its forward PE of 11.6 is well below the industry average of 16.4, suggesting the stock is undervalued. The DCF‑derived fair value of roughly $362 implies an upside of over 30% from current levels, and the dividend yield of 1.5% is backed by a modest 21.8% payout ratio, making the dividend sustainable. Analysts are broadly positive, with a consensus “Buy” rating, a median 12‑month target near $335, and recent upgrades from Citigroup, reinforced by high‑profile investor interest. Together, these fundamentals and sentiment outweigh the short‑term bearish technical signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Oversold RSI suggests potential near‑term bounce
  • Price below key moving averages indicates bearish bias
  • Increasing volume supports short‑term support level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant upside to DCF fair value
  • Strong earnings growth and margins
  • Positive analyst consensus and recent upgrades

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Stable cash flow and solid ROE
  • Low beta indicating limited market‑wide volatility exposure

Key Metrics & Analysis

Financial Health

Revenue Growth8.50%
Profit Margin16.84%
P/E Ratio15.1
ROE20.61%
ROA5.09%
Debt/Equity85.69
P/B Ratio3.1
Op. Cash Flow$1.8B
Free Cash Flow$2.1B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI31.7
Support$246.61
Resistance$300.98
MA 20$279.78
MA 50$287.00
MA 200$315.44
MACDBearish
VolumeIncreasing
Fear & Greed Index90.73

Valuation

Fair Value$361.59
Target Price$336.21
Upside/Downside31.15%
GradeUndervalued
TypeBlend
Dividend Yield1.50%

Risk Assessment

Beta0.07
Volatility42.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.